$DOX

Amdocs Limited Just Missed Earnings - But Analysts Have Updated Their Models

Amdocs reported Q3 results. Revenue of about $1.2b met analyst expectations, but statutory EPS of $0.59 missed estimates by 59%. After the report, five analysts raised 2027 revenue forecasts to $4.85b and EPS to $6.95 (from $6.67). The consensus price target fell 10% to $81.21, with targets ranging $70.84 to $105.

Original reporting
Published Aug 9, 2026, 12:05 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 10, 2026, 1:28 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Amdocs Limited Just Missed Earnings - But Analysts Have Updated Their Models — source image
Decision brief

The 30-second read

$DOXNeutralMed
01

Why it matters

Analysts became more bullish on earnings (2027 EPS +62%) while keeping revenue expectations steady (2027 revenue $4.85b, reconfirmed). However, the consensus price target dropped 10%, implying investors may be discounting the earnings quality or growth multiple despite higher EPS estimates.

02

Market read

Traders can use the combination of upgraded EPS and reduced consensus PT to gauge whether the market is pricing improved earnings or applying a lower multiple.

03

What to watch

The article lacks segment margin, guidance details beyond 2027 consensus, and management commentary, which are often the real drivers behind PT revisions.

Relevance 6/10Novelty 5/10Timing: post-earnings, after-hours/next-session positioning following Q3 results and updated 2027 forecasts

Background

The piece reviews post-Q3 analyst forecast updates for Amdocs and compares the implied 2027 growth profile to recent history and industry peers.

Company-level read

Ticker impact

$DOXNeutralMedium confidence
Context

Amdocs shares rose 5.1% after Q3 results, while analysts upgraded 2027 EPS to $6.95 but cut the consensus price target 10% to $81.21.

Expected impact

Near-term bias is mixed, with support from upgraded EPS offset by valuation caution implied by the lower price target.

Evidence & confidence

The article provides explicit forecast changes (EPS up, revenue flat) and a specific PT cut, which typically drives positioning around valuation rather than fundamentals alone.

Market effects

Signals that telecom software/services peers may see valuation pressure even when earnings outlook improves, depending on growth vs industry.

No specific regional spillover is described beyond the US-listed share reaction.

No explicit global macro or cross-border deal/regulatory driver is cited.

Counterpoint

The PT cut may reflect analysts’ valuation discipline rather than deteriorating fundamentals, so the EPS upgrade could still support upside if execution matches the higher earnings trajectory.

Key entities

  • Amdocs Limited

    Telecom software/services company whose Q3 results and subsequent analyst model updates are discussed.

  • Amdocs analysts (5)

    The article summarizes their updated 2027 revenue and EPS forecasts and the resulting consensus price target range.

Related articles

$DOXMedAI 8/10

Amdocs (DOX) Q3 2026 Earnings Call Transcript

Amdocs (DOX) reported Q3 FY2026 revenue of $1.175B, up 2.2% in constant currency, and non-GAAP diluted EPS of $1.84. Non-GAAP operating margin was 21.6%. Managed services revenue was $791M and 12-month backlog $4.26B. Full-year guidance: revenue 2.6% to 3.4% (midpoint 3%), non-GAAP EPS growth midpoint 6%, free cash flow $710M to $730M. A $0.91/share restructuring charge drove GAAP EPS to $0.59.

$DOXMedAI 8/10

AMDOCS LTD (DOX): Financial results for Q3 2026

AMDOCS LTD (DOX) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Amdocs Limited Reports Third Quarter Fiscal 2026 Results Revenue of $1.17 Billion, up 2.7% YoY as Reported and up 2.2% YoY in Constant Currency (1) Expects Fiscal 2026 Revenue Growth Outlook of 3.2%-4.0% YoY as Reported Reiterates Midpoint of Fiscal 2026 Revenue Grow

$DOXMedAI 8/10

Amdocs Limited Reports Third Quarter Fiscal 2026 Results

Amdocs (NASDAQ:DOX) reported Q3 fiscal 2026 revenue of $1.175B, up 2.7% YoY as reported and 2.2% in constant currency. Managed services revenue was $791M (about 67%). GAAP diluted EPS was $0.59 and non-GAAP diluted EPS $1.84. It expects FY2026 revenue growth of 3.2% to 4.0% (reported) and signed a 10-year partnership with Liberty Latin America.

$DOXMedAI 8/10

Amdocs - IR: Amdocs Limited Reports Third Quarter Fiscal 2026 Results

Amdocs Limited (NASDAQ:DOX) reported Q3 FY2026 revenue of $1.175B, up 2.7% YoY (2.2% constant currency). Managed services revenue was $791M, about 67% of total. GAAP diluted EPS was $0.59 after a restructuring charge; non-GAAP EPS was $1.84. It expects FY2026 revenue growth of 3.2% to 4.0% (reported) and 2.6% to 3.4% (constant currency) and signed a 10-year IT transformation deal with Liberty Latin America.

$EQIXMedAI 8/10

Equinix Is Doubling Down on AI Data Centers. How to Play EQIX Stock Here

Equinix (EQIX) reported Q2 revenue of $2.63B, up 16% YoY, beating estimates. AFFO was $11.78/share, up 19% YoY. The company raised full-year guidance and unveiled a multi-year growth plan. EQIX stock has surged 34% over the past year and offers a 1.98% dividend yield. Analysts rate it a 'Strong Buy' with an average price target of $1,232.19.